4//SEC Filing
Strem Brian M. 4
Accession 0001104659-22-111239
CIK 0001372514other
Filed
Oct 24, 8:00 PM ET
Accepted
Oct 25, 5:30 PM ET
Size
7.7 KB
Accession
0001104659-22-111239
Insider Transaction Report
Form 4
Strem Brian M.
DirectorPresident and CEO
Transactions
- Award
Common Stock
2022-10-21+12,500→ 13,183 total - Award
Stock Option (right to buy)
2022-10-21+18,750→ 18,750 totalExercise: $6.78Exp: 2032-10-21→ Common Stock (18,750 underlying)
Footnotes (2)
- [F1]Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan (the "Plan"). The restrictions will vest as to one-third (1/3) of the shares on each of October 21, 2023, October 21, 2024 and October 21, 2025, subject to the reporting person's continuous service through each such vesting date.
- [F2]The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on October 21, 2023, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date.
Documents
Issuer
KIORA PHARMACEUTICALS INC
CIK 0001372514
Entity typeother
Related Parties
1- filerCIK 0001876429
Filing Metadata
- Form type
- 4
- Filed
- Oct 24, 8:00 PM ET
- Accepted
- Oct 25, 5:30 PM ET
- Size
- 7.7 KB